The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
Global At-Home Drug of Abuse (DOA) Testing market size will increase to 950 Million US$ by 2026, from 430 Million US$ in 2020, at a CAGR of 10.6% during the forecast period. In this study, 2020 has been considered as the base year and 2021 to 2026 as the forecast period to estimate the market size for At-Home Drug of Abuse (DOA) Testing.
This report covers the present status and the future prospects of the global At-Home Drug of Abuse (DOA) Testing market for 2015-2026.
The report offers detailed coverage of At-Home Drug of Abuse (DOA) Testing industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading At-Home Drug of Abuse (DOA) Testing by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
UCP Biosciences Inc., Orient New Life Medical Co. Ltd., Express Diagnostics Int\'l Inc., Assure Tech (Hangzhou) Co. Ltd., Psychemedics Corporation, Confirm BioSciences, Phamatech Inc., Home Health (U.K.) Ltd., Quest Products Inc.
Market Segment as follows:
Market by Order Type
Test Cups
Test Dip Cards
Test Strips
Others
At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application
Urine
Saliva
Hair
Others
At-Home Drug of Abuse (DOA) Testing Production market while maintaining their competitive edge over their competitors. The report offers detailed and crucial information to understand the overall market scenario.
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the At-Home Drug of Abuse (DOA) Testing market for the forecast period 2021 - 2026?
• What are the driving forces in the At-Home Drug of Abuse (DOA) Testing market for the forecast period 2021 - 2026?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the At-Home Drug of Abuse (DOA) Testing industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.